Nitazoxanide Exerts Immunomodulatory Effects on Peripheral Blood Mononuclear Cells from Type 2 Diabetes Patients

Background: Type 2 diabetes (T2D) is a low-grade inflammatory condition with abnormalities in the immune response mediated by T lymphocytes and macrophages. Drug repositioning for immunomodulatory molecules is an attractive proposal for treating T2D. Nitazoxanide (NTZ) is a broad-spectrum drug with...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Mauricio Castillo-Salazar, Fausto Sánchez-Muñoz, Rashidi Springall del Villar, Gabriel Navarrete-Vázquez, Adrián Hernández-DiazCouder, Carlos Mojica-Cardoso, Sara García-Jiménez, Cairo Toledano-Jaimes, Germán Bernal-Fernández
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2021-12-01
Cyfres:	Biomolecules
Pynciau:	immunomodulation nitazoxanide inflammation T2D miRNAs
Mynediad Ar-lein:	https://www.mdpi.com/2218-273X/11/12/1817
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!